Arcus Capital Expenditures from 2010 to 2025

RCUS Stock  USD 10.89  1.01  10.22%   
Arcus Biosciences Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures is likely to outpace its year average in 2025. From the period from 2010 to 2025, Arcus Biosciences Capital Expenditures quarterly data regression had r-value of  0.53 and coefficient of variation of  96.05. View All Fundamentals
 
Capital Expenditures  
First Reported
2016-12-31
Previous Quarter
1000 K
Current Value
1000 K
Quarterly Volatility
2.7 M
 
Covid
Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 50.4 M, Interest Income of 54.6 M or Depreciation And Amortization of 6.7 M, as well as many indicators such as Price To Sales Ratio of 4.94, Dividend Yield of 0.0 or PTB Ratio of 3.36. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Arcus Biosciences over the last few years. Capital Expenditures are funds used by Arcus Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Arcus Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Arcus Biosciences' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

Arcus Capital Expenditures Regression Statistics

Arithmetic Mean7,598,107
Geometric Mean5,664,370
Coefficient Of Variation96.05
Mean Deviation5,280,910
Median4,099,000
Standard Deviation7,298,300
Sample Variance53.3T
Range24.2M
R-Value0.53
Mean Square Error41.1T
R-Squared0.28
Significance0.03
Slope811,785
Total Sum of Squares799T

Arcus Capital Expenditures History

202510.6 M
2024M
202324 M
202212 M
202126.1 M
20203.1 M
20191.9 M

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital ExpendituresM10.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.